P. Y. Le Prise

Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly.

Hervé Tilly, Sylvie Castaigné, Dominique Bordessoule et al. · Journal of Clinical Oncology · 1990 · 258 citations

Medicine, Oncology, Pharmacotherapy +17

A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM).

Francis Witz, Alain Sadoun, M. C. Perrin et al. · PubMed · 1998 · 147 citations

Medicine, Hematology, Pharmacology +10

Inapparent Polycythemia Vera: An Unrecognized Diagnosis

Thierry Lamy, Anne Devillers, Marc Bernard et al. · The American Journal of Medicine · 1997 · 86 citations

Medicine, Hematology, Internal Medicine +4

Granulocyte Colony-Stimulating Factor After Intensive Consolidation Chemotherapy in Acute Myeloid Leukemia: Results of a Randomized Trial of the Groupe Ouest-Est Leucémies Aigues Myeloblastiques

Jean‐Luc Harousseau, Brigitte Witz, Bruno Lioure et al. · Journal of Clinical Oncology · 2000 · 83 citations

Medicine, Hematology, Oncology +15

Mediastinal tumor size and response to chemotherapy are the only prognostic factors in supradiaphragmatic Hodgkin's disease treated by ABVD plus radiotherapy: ten-year results of the Paris-Ouest-France 81/12 trial, including 262 patients.

P Colonna, Jean‐Philippe Jaïs, B Desablens et al. · Journal of Clinical Oncology · 1996 · 48 citations

Medicine, Oncology, Radiation Oncology +17